Dr. David C. Weksberg, MD

Dr. Weksberg practices at UPMC Harrisburg in Harrisburg, Pennsylvania.

Dr. Weksberg's NPI, 1093947954, was assigned on August 11, 2009. Dr. Weksberg graduated from Baylor College of Medicine in 2009. Dr. Weksberg holds Pennsylvania license MD451298.

Dr. Weksberg's primary practice is UPMC Harrisburg, at 111 S Front St, Harrisburg, PA 17101 in Dauphin County. The practice phone is (717) 230-3790.

Dr. Weksberg's primary practice is UPMC Harrisburg in Harrisburg, Pennsylvania. Dr. Weksberg is also affiliated with UPMC Harrisburg. The medical group on file is UPMC Pinnacle Health Systems. Dmand AI also links Dr. Weksberg to 4 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weksberg practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Weksberg's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Weksberg is licensed in Pennsylvania.

CMS data shows 1,310 Medicare services from Dr. Weksberg across 13 procedure codes in 2024, for 199 Medicare patients. Medicare paid $85,233 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Dr. Weksberg in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weksberg's median patient age at 74, with 18% women.

In 2024, Dr. Weksberg wrote 125 Medicare Part D claims for 51 patients. 96% of them were for generic drugs. CMS names the drug for 84 of them, across 2 drugs with 11 or more claims each, at $3,263 in total drug cost. In 2023, CMS named 95 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Weksberg for performance year 2024, reported as part of a group. Dr. Weksberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weksberg as offering telehealth.

Dmand AI links 13 papers to Dr. Weksberg, published from 2011 to 2021. 2011 was the busiest year, with 4. The most frequent topics are Radiotherapy Dosage. Dr. Weksberg has published most often in Cancers (Basel). Dr. Weksberg's most frequent co-authors are Jillian Rebecca Gunther, MD, Sunil Krishnan, MD and Syed Shabaz Azeem, MD.

Dmand AI links Dr. Weksberg to 2 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Glioblastoma and Astrocytoma. NRG Oncology sponsors the most, 2.

CMS Open Payments shows 13 general payments to Dr. Weksberg from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Foundation Medicine, Inc. paid the most, $407.

Dr. Weksberg graduated from Baylor College of Medicine in 2009.